Literature DB >> 23605591

Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoise.

Suresh Senan.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23605591     DOI： 10.1002/cncr.28101

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 2.  Recent advances in radiotherapy for thoracic tumours.

Authors:  Michael Fay; Christopher M Poole; Gary Pratt
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Authors:  Alexander V Louie; George B Rodrigues; David A Palma; Suresh Senan
Journal:  Oncologist       Date:  2014-06-20

Review 4.  Is surgery still the best management option for early stage NSCLC?

Authors:  Aurel Ottlakan; Nicola Martucci; Gaetano Rocco
Journal:  Transl Lung Cancer Res       Date:  2014-06

5.  Misjudgement of gefitinib efficacy in patients with central non-small-cell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy.

Authors:  Xueqin Yang; Yanli Xiong; Huan Huang; Bo Peng; Zejun Zhou; Mingfang Xu; Yi Yang; Dong Wang
Journal:  Mol Clin Oncol       Date:  2014-04-30

Review 6.  Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials.

Authors:  Michael Troncone; Stephanie M Cargnelli; Linda A Villani; Naghmeh Isfahanian; Lindsay A Broadfield; Laura Zychla; Jim Wright; Gregory Pond; Gregory R Steinberg; Theodoros Tsakiridis
Journal:  Oncotarget       Date:  2017-04-27

7.  Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer.

Authors:  Naoki Nakamura; Hidehiro Hojo; Kazuya Inoue; Kenji Hotta; Sadamoto Zenda; Hiromi Baba; Masakatsu Onozawa; Atsushi Motegi; Masaki Nakamura; Yuichi Kibe; Tetsuo Akimoto
Journal:  J Radiat Res       Date:  2018-07-01       Impact factor: 2.724
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.